the balanced life semaglutide Oral Photo by Linda Alfieri Accetta

Efficacy Results at Week 72 in Adult Patients with Noncirrhotic MASH with Stage 2 or Stage 3 Fibrosis in Study 11 of WEGOVY Injection * Results were statistically significant

Because the medication directly impacts your digestive system, the vast majority of side effects are gastrointestinal

Semaglutide is a GLP-1 receptor agonist that has been widely studied for its effects on appetite regulation, glucose metabolism, and body weight management

How you eat while taking them can significantly influence: Muscle preservation Metabolic health Inflammation levels Long-term outcomes Clinical trials of GLP-1 receptor agonists and tirzepatide show that a meaningful portion of weight loss can come from lean body mass (muscle) , particularly in the absence of targeted nutrition and resistance exercise strategies (Jastreboff et al., 2022